Skip to main content
. Author manuscript; available in PMC: 2022 Oct 1.
Published in final edited form as: Clin Gastroenterol Hepatol. 2020 Oct 1;19(10):2128–2137.e15. doi: 10.1016/j.cgh.2020.09.054

Table 3.

Age-group stratified familial risk of incident UC and CD with affected FDR of the same subtype according to type of family relationship

Age group (years) With affected father* With affected mother* With affected sibling* With affected twin* With more than oneaffected FDR* With positive family history* No family history of IBD)

N (%) IRRs (95% CI) N (%) IRRs (95% CI) N (%) IRRs (95% CI) N (%) IRRs (95% CI) N (%) IRRs (95% CI) Person-years N (%) IRRs (95% CI) Person-years N (%)

CD
0 to <10 0 - 1(5) 15.93(0.4–89.53) 5(1) 47.37(15.2–111.9) 0 - 0 - 83,891 6(1) 19.63 (7.14–43.32) 70,542,448 257(2)
10 to <20 29(78) 15.12(10.1–21.7) 10(50) 8.27(3.96–15.23) 165(54) 34.06(29–39.77) 18(60) 379.4(224.69–600.17) 6(60) 138.23(50.71–301.05) 125,009 228(57) 28.28(24.67–32.29) 87,510,480 5643(19)
20 to <30 7(19) 5.09(2.05–10.50) 6(35) 5.36(1.97–11.67) 113(38) 24.04(19.7–28.9) 12(40) 352.4(181.97–616.11) 3(30) 80.14(16.52–234.33) 116,182 141(36) 19.41(16.30–22.94) 80,635,807 5043(42)
30 to <40 1(3) 2.32(0.06–12.93) 2(10) 4.91(0.59–17.77) 19(6) 15.34(9.2–24.0) 0 - 3(10) 102.41(2.59–571.37) 61,269 23(6) 10.99(6.94–16.54) 48,287,779 1650(26)
40 to <50 0 - 0 - 2(1) 14.88(1.7–54.1) 0 - 0 - 14,274 2(0) 6.83(0.82–24.88) 15,605,220 320(8)
50 + 0 - 0 - 0 - 0 - 0 - 2,429 0 - 4,422,586 70(3)
Total 37 9.40(6.81–12.98) 19 6.54(4.17–10.25) 304 27.56(24.5–30.8) 30 336.21(234.96–481.08) 10 107.52(57.84–199.89) 403,054 400 22.15(20.05–24.47) 307,000,000 12983
UC
0 to <10 1(1) 2.60(0.07–14.60) 3(2) 11.42(2.3–33.7) 5(2) 74.84(24.1–176.8) 0 - 0 - 190,012 9(2) 12.51(5.6–24.1) 70,542,448 267(2)
10 to<20 46(28) 10.75(7.8–14.3) 39(27) 13.66(9.6–18.7) 60(29) 30.33(23.08–39.15) 6(30) 284.63(104.36–620.2) 8(21) 120.35(51.9–237.4) 280,616 159(28) 17.23(14.6–20.2) 87,510,480 2877(19)
20 to <30 71(43) 7.07(5.51–8.93) 67(46) 9.67(7.48–12.92) 84(42) 11.73(9.34–14.54) 11(55) 182.45(91.03–326.68) 25(66) 104.23(67.4–154) 315,036 258(45) 10.54(9.2–11.9) 80,635,807 6268(42)
30 to <40 35(21) 5.51(3.83–7.67) 27(18) 5.77(3.8–8.41) 45(21) 8.84(6.44–11.85) 2(10) 67.02(8.11–242.28) 5(13) 29.68(9.63–69.33) 202,375 114(20) 6.97(5.7–8.4) 48,287,779 3902(26)
40 to <50 11(6) 6.37(3.17–11.43) 11(7) 7.19(3.58–12.92) 11(5) 9.18(4.57–16.49) 1(5) 114.76(2.9–640.55) 0 - 56,474 34(6) 7.54(5.2–10.5) 15,605,220 1246(8)
50 + 1(1) 2.38(0.06–13.33) 0 - 1(1) 4.09(0.1–22.91) 0 - 0 - 12,173 2(1) 1.70(0.2–6.1) 4,422,586 428(3)
Total 165 7.11(6.10–8.29) 147 8.77(7.46–10.32) 206 13.09(11.41–15.02) 20 163.73(105.60–253.86) 38 72.36(52.63–99.49) 1,056,686 576 10.2(9.3–11.0) 307,000,000 14,988
*

Familial risk of incident IBD with same subtype of affected FDR (e.g. risk of UC with UC affected FDR)

N – number of individuals, IBD – inflammatory bowel disease, UC - ulcerative colitis, CD - Crohn’s disease, FDR – first degree relatives, IRR – incidence risk ratio,